Device Trial Radar · NCT03320863
The Enso Study for Chronic Low Back Pain
Last checked: Nov 19, 2026Latest source record: Jan 27, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
50
Planned (sponsor's estimate)
Start
Nov 9, 2017
Primary completion
Dec 30, 2020
Study completion Jan 30, 2021
Sponsor
- Lead sponsor
- Thimble Bioelectronics, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- University of California, San Francisco
- First posted
- Oct 25, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Enso is a portable device for the treatment of chronic and acute types of musculoskeletal pain. This study is being designed as a double-blinded, sham-controlled randomized clinical trial.
Conditions
- Chronic Low Back Pain
Interventions
Enso deviceDevice
An active Enso device that delivers neuromodulation therapy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Six Minute Walk TestTime frame: Once a week for 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California Medical Center
San Francisco, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.